Get started
111

CHORDIA THERAPEUTICS INC

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

190A chart


Full chart

190A upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪16.83 B‬ JPY
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−1.83 B‬ JPY
Revenue (FY)
0.00 JPY
Shares float
‪12.25 M‬
Beta (1Y)
0.48

Employees


Employees (FY)
22
Change (1Y)
+1 +4.76%
Revenue / Employee (1Y)
0.00 JPY
Net income / Employee (1Y)
‪−83.05 M‬ JPY

About CHORDIA THERAPEUTICS INC


Sector
Health Technology
CEO
Hiroshi Miyake
Headquarters
Fujisawa
Website
chordiatherapeutics.com
Founded
2017
ISIN
JP3283730004
FIGI
BBG01HTQQWW8
Chordia Therapeutics, Inc. engages in the research and development of novel therapies for cancers. It handles research and development of low-molecular-weight drugs with unprecedented new mechanisms of action in the oncology area. The company was founded by Hiroshi Miyake and Daisuke Morishita on October 12, 2017 and is headquartered in Fujisawa, Japan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

190A news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 190A is 276 JPY — it has increased by 7.29% in the past 24 hours. Watch CHORDIA THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange CHORDIA THERAPEUTICS INC stocks are traded under the ticker 190A.
190A stock has risen by 11.81% compared to the previous week, the month change is a 25.59% rise, over the last year CHORDIA THERAPEUTICS INC has showed a 8.24% increase.
190A reached its all-time high on Aug 14, 2024 with the price of 930 JPY, and its all-time low was 142 JPY and was reached on Jun 21, 2024. View more price dynamics on 190A chart.
See other stocks reaching their highest and lowest prices.
190A stock is 11.67% volatile and has beta coefficient of 0.48. Track CHORDIA THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is CHORDIA THERAPEUTICS INC there?
Yes, you can track CHORDIA THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
CHORDIA THERAPEUTICS INC is going to release the next earnings report on Jan 14, 2025. Keep track of upcoming events with our Earnings Calendar.
190A net income for the last quarter is ‪−649.65 M‬ JPY, while the quarter before that showed ‪−374.87 M‬ JPY of net income which accounts for −73.30% change. Track more CHORDIA THERAPEUTICS INC financial stats to get the full picture.
No, 190A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 22.00 employees. See our rating of the largest employees — is CHORDIA THERAPEUTICS INC on this list?
Like other stocks, 190A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHORDIA THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.